Cargando…
The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy
Myostatin, a muscle-specific transforming growth factor-β (TGF-β), negatively regulates skeletal muscle mass. The N-terminal prodomain of myostatin noncovalently binds to and suppresses the C-terminal mature domain (ligand) as an inactive circulating complex. However, which region of the myostatin p...
Autores principales: | Ohsawa, Yutaka, Takayama, Kentaro, Nishimatsu, Shin-ichiro, Okada, Tadashi, Fujino, Masahiro, Fukai, Yuta, Murakami, Tatsufumi, Hagiwara, Hiroki, Itoh, Fumiko, Tsuchida, Kunihiro, Hayashi, Yoshio, Sunada, Yoshihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520684/ https://www.ncbi.nlm.nih.gov/pubmed/26226340 http://dx.doi.org/10.1371/journal.pone.0133713 |
Ejemplares similares
-
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial
por: Ohsawa, Yutaka, et al.
Publicado: (2019) -
Highly Specific Detection of Myostatin Prodomain by an Immunoradiometric Sandwich Assay in Serum of Healthy Individuals and Patients
por: Breitbart, Astrid, et al.
Publicado: (2013) -
Local Applications of Myostatin-siRNA with Atelocollagen Increase Skeletal Muscle Mass and Recovery of Muscle Function
por: Kawakami, Emi, et al.
Publicado: (2013) -
Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model
por: Hanada, Kako, et al.
Publicado: (2022) -
Peptide‐2 from mouse myostatin precursor protein alleviates muscle wasting in cancer‐associated cachexia
por: Ojima, Chiharu, et al.
Publicado: (2020)